drugset
drugset / Trial / NCT01144299

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

NCT01144299 ↗

Phase 3 Completed 114 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This study is designed to test the immunogenicity and reactogenicity of the Fluarix™/Influsplit SSW® influenza vaccine containing the influenza strains recommended for the 2010-2011 season.

Timeline

Start
2010-06-17
Primary completion
2010-07-10
Completion
2010-07-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine — Intramuscular

Indications

influenza